Dosage and administration
Children 2 to 12: Administer one drop under the tongue for each year of age, 3 times per day. Children 1 & under: use one drop per dose. Consult a physician for use in children under 12 years of age.
Children 2 to 12: Administer one drop under the tongue for each year of age, 3 times per day. Children 1 & under: use one drop per dose. Consult a physician for use in children under 12 years of age.
(in each drop): 10% Belladonna 200C, Cantharis 200C, Causticum 200C, Cina 6X, Equisetum Hyemale 3X, Ignatia Amara 200C, Physalis Alkekengi 3X, Sepia 200C, Uranium Nitricum 12X, Verbascum Thapsus 3X.
May temporarily relieve childhood bedwetting, "accidents," and for urinary tract support.**
**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
If symptoms persist for more than 7 days, consult a doctor.
Keep out of reach of children. In case of overdose, get medical help or call a Poison Control Center right away.
Do not use if TAMPER EVIDENT seal around neck of bottle is missing or broken.
Children 2 to 12: Administer one drop under the tongue for each year of age, 3 times per day.
Children 1 & under: use one drop per dose. Consult a physician for use in children under 12 years of age.
Glycerin, Organic alcohol 9% v/v, Purified water.
Keep out of reach of children. In case of overdose, get medical help or call a Poison Control Center right away.
May temporarily relieve childhood bedwetting, "accidents," and for urinary tract support.**
**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
ORAL DROPS
LIDDELL
LABORATORIES
EST. 1994
18 Bdw
Bedwetting
HOMEOPATHIC
1.0 FL. OZ. (30 ml)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50845-0177-1 | 2022-05-25 | C162847 | 48780-1 | 9d75b9d0-37a8-f424-e053-dadaa90a57ce | Drug Facts: |
| 50845-0177-1 | 2022-01-28 | C162847 | 48780-1 | 9d75b9d0-37a8-f424-e053-dadaa90a57ce | Drug Facts: |
| 50845-0177-1 | 2020-10-22 | C162847 | 48780-1 | 9d75b9d0-37a8-f424-e053-dadaa90a57ce | Drug Facts: |
| 50845-0177-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-37a8-f424-e053-dadaa90a57ce | Drug Facts: |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ARTEMISIA CINA PRE-FLOWERING TOP | ACTIVE INGREDIENT | 28M1820ACT | 2 | |
| ATROPA BELLADONNA | ACTIVE INGREDIENT | WQZ3G9PF0H | 2 | |
| CAUSTICUM | ACTIVE INGREDIENT | DD5FO1WKFU | 2 | |
| EQUISETUM HYEMALE | ACTIVE INGREDIENT | 59677RXH25 | 2 | |
| LYTTA VESICATORIA | ACTIVE INGREDIENT | 3Q034RO3BT | 2 | |
| PHYSALIS ALKEKENGI FRUIT | ACTIVE INGREDIENT | 2042VC712P | 2 | |
| SEPIA OFFICINALIS JUICE | ACTIVE INGREDIENT | QDL83WN8C2 | 2 | |
| STRYCHNOS IGNATII SEED | ACTIVE INGREDIENT | 1NM3M2487K | 2 | |
| URANYL NITRATE HEXAHYDRATE | ACTIVE INGREDIENT | 3V057702FY | 2 | |
| VERBASCUM THAPSUS | ACTIVE INGREDIENT | C9TD27U172 | 2 | |
| ARTEMISIA CINA FLOWER | ACTIVE MOIETY | 28M1820ACT | 2 | |
| ATROPA BELLADONNA | ACTIVE MOIETY | WQZ3G9PF0H | 2 | |
| CAUSTICUM | ACTIVE MOIETY | DD5FO1WKFU | 2 | |
| EQUISETUM HYEMALE | ACTIVE MOIETY | 59677RXH25 | 2 | |
| LYTTA VESICATORIA | ACTIVE MOIETY | 3Q034RO3BT | 2 | |
| PHYSALIS ALKEKENGI FRUIT | ACTIVE MOIETY | 2042VC712P | 2 | |
| SEPIA OFFICINALIS JUICE | ACTIVE MOIETY | QDL83WN8C2 | 2 | |
| STRYCHNOS IGNATII SEED | ACTIVE MOIETY | 1NM3M2487K | 2 | |
| URANIUM CATION (6+) | ACTIVE MOIETY | 5PI36AS4G7 | 2 | |
| VERBASCUM THAPSUS | ACTIVE MOIETY | C9TD27U172 | 2 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50845-0177 | 50845-0177-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ATROPA BELLADONNA | WQZ3G9PF0H | ACTIB |
| LYTTA VESICATORIA | 3Q034RO3BT | ACTIB |
| CAUSTICUM | DD5FO1WKFU | ACTIB |
| ARTEMISIA CINA PRE-FLOWERING TOP | 28M1820ACT | ACTIB |
| EQUISETUM HYEMALE | 59677RXH25 | ACTIB |
| STRYCHNOS IGNATII SEED | 1NM3M2487K | ACTIB |
| PHYSALIS ALKEKENGI FRUIT | 2042VC712P | ACTIB |
| SEPIA OFFICINALIS JUICE | QDL83WN8C2 | ACTIB |
| URANYL NITRATE HEXAHYDRATE | 3V057702FY | ACTIB |
| VERBASCUM THAPSUS | C9TD27U172 | ACTIB |
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9e8a8231-a1b9-4a37-b0da-659560261a33 | b32497e9-6ee4-47a2-9f7a-f3787beb2aa5 | 2022-05-25 | Warnings | 9e8a8231-a1b9-4a37-b0da-659560261a33 b32497e9-6ee4-47a2-9f7a-f3787beb2aa5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.